First Eagle Investment Management LLC Has $10.29 Million Stake in Teleflex Incorporated $TFX

First Eagle Investment Management LLC increased its stake in shares of Teleflex Incorporated (NYSE:TFX) by 163.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 84,300 shares of the medical technology company’s stock after acquiring an additional 52,300 shares during the period. First Eagle Investment Management LLC’s holdings in Teleflex were worth $10,288,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in TFX. Hantz Financial Services Inc. raised its holdings in shares of Teleflex by 248.8% during the third quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock worth $34,000 after acquiring an additional 199 shares during the period. Mirae Asset Global Investments Co. Ltd. acquired a new stake in Teleflex in the 3rd quarter valued at $35,000. V Square Quantitative Management LLC acquired a new stake in Teleflex in the 4th quarter valued at $37,000. Quent Capital LLC acquired a new stake in Teleflex in the 3rd quarter valued at $38,000. Finally, Cullen Frost Bankers Inc. increased its stake in Teleflex by 496.7% in the 3rd quarter. Cullen Frost Bankers Inc. now owns 358 shares of the medical technology company’s stock valued at $44,000 after buying an additional 298 shares during the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

More Teleflex News

Here are the key news stories impacting Teleflex this week:

• Positive Sentiment: Truist Financial reaffirmed its Hold rating on Teleflex and raised its price target to $143 from $135, implying upside from current trading levels. Teleflex’s (TFX) “Hold” Rating Reaffirmed at Truist Financial
• Positive Sentiment: Needham & Company reiterated a Buy view with a $147 price objective and issued upbeat longer-term earnings forecasts, including $12.18 EPS for FY2028 and $2.90 EPS for Q1 2028. Needham & Company estimate update
• Positive Sentiment: Citizens JMP also published optimistic estimates for Teleflex, projecting $10.50 EPS for FY2027 and quarterly earnings rising through 2027, which supports the view that profit growth could accelerate over the next few years. Citizens JMP estimate update
• Neutral Sentiment: Citizens JMP’s quarterly forecasts for 2027, including $2.03 in Q1, $2.62 in Q2, $2.83 in Q3, and $3.05 in Q4, mainly reinforce the firm’s longer-term earnings outlook rather than providing a near-term catalyst. Citizens JMP quarterly estimate update

Wall Street Analyst Weigh In

Several brokerages have issued reports on TFX. Royal Bank Of Canada upgraded shares of Teleflex from a “sector perform” rating to an “outperform” rating and lifted their price target for the company from $135.00 to $155.00 in a research note on Friday. Wall Street Zen lowered shares of Teleflex from a “hold” rating to a “sell” rating in a research note on Saturday. Mizuho set a $140.00 price target on shares of Teleflex in a research note on Friday. Truist Financial reiterated a “hold” rating and issued a $143.00 price target (up from $135.00) on shares of Teleflex in a research note on Monday. Finally, Raymond James Financial reiterated an “outperform” rating and issued a $150.00 price target on shares of Teleflex in a research note on Friday. Three investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $144.00.

Teleflex Stock Performance

Shares of TFX opened at $129.00 on Wednesday. The firm has a 50-day moving average of $120.22 and a 200-day moving average of $116.70. Teleflex Incorporated has a one year low of $100.18 and a one year high of $139.67. The company has a market cap of $5.71 billion, a PE ratio of -5.66, a price-to-earnings-growth ratio of 0.95 and a beta of 0.82. The company has a debt-to-equity ratio of 0.82, a current ratio of 2.55 and a quick ratio of 2.03.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, beating analysts’ consensus estimates of $1.21 by $0.18. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The company had revenue of $548.30 million during the quarter, compared to the consensus estimate of $536.91 million. During the same quarter last year, the firm posted $1.44 EPS. The company’s quarterly revenue was up 32.3% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, equities analysts forecast that Teleflex Incorporated will post 6.8 earnings per share for the current year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Friday, March 6th were given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date of this dividend was Friday, March 6th. Teleflex’s dividend payout ratio (DPR) is -5.96%.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.